Citation: F. Kuhnregnier et al., CORONARY OXYGEN PERSUFFLATION FOR LONG-TERM MYOCARDIAL PROTECTION, The thoracic and cardiovascular surgeon, 46, 1998, pp. 308-312
Citation: Jh. Fischer et al., STABILITY OF FOSPHENYTOIN SODIUM WITH INTRAVENOUS SOLUTIONS IN GLASS BOTTLES, POLYVINYL-CHLORIDE BAGS, AND POLYPROPYLENE SYRINGES, The Annals of pharmacotherapy, 31(5), 1997, pp. 553-559
Authors:
CUNNINGHAM FE
ROGERS S
FISCHER JH
JENSEN RC
Citation: Fe. Cunningham et al., THE PHARMACOKINETICS OF DEXAMETHASONE IN THE THOROUGHBRED RACEHORSE, Journal of veterinary pharmacology and therapeutics, 19(1), 1996, pp. 68-71
Authors:
RAMSAY RE
PHILBROOK B
FISCHER JH
SLOAN EP
ALLEN FH
RUNGE JW
SMITH MF
KUGLER AR
Citation: Re. Ramsay et al., SAFETY AND PHARMACOKINETICS OF FOSPHENYTOIN (CEREBYX) COMPARED WITH DILANTIN FOLLOWING RAPID INTRAVENOUS ADMINISTRATION, Neurology, 46(2), 1996, pp. 3063-3063
Citation: Jh. Fischer et S. Jeschkeit, EFFECTIVITY OF FRESHLY PREPARED OR REFRESHED SOLUTIONS FOR HEART PRESERVATION VERSUS COMMERICAL EUROCOLLINS, BRETSCHNEIDERS HTK, OR UNIVERSITY-OF-WISCONSIN SOLUTION, Transplantation, 59(9), 1995, pp. 1259-1262
Authors:
ALLEN FH
RUNGE JW
LEGARDA S
MARIA BL
MATSUO F
FISCHER JH
KUGLER AR
BASSON SM
Citation: Fh. Allen et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF INTRAVENOUS FOSPHENYTOIN (CEREBYX(R)) STATUS EPILEPTICUS, Epilepsia, 36, 1995, pp. 7-7
Authors:
FISCHER PA
SLOAN EP
TURNBULL TL
PALOUCEK FP
DELACRUZ FG
FISCHER JH
Citation: Pa. Fischer et al., SAFETY AND PHARMACOKINETICS OF INTRAVENOUS LOADING DOSES OF FOSPHENYTOIN FOR ACUTE TREATMENT OF SEIZURES, Epilepsia, 36, 1995, pp. 160-160
Authors:
OCCHIPINTI DJ
CHOI A
DEYO K
DANZIGER LH
FISCHER JH
Citation: Dj. Occhipinti et al., INFLUENCE OF RIFAMPIN AND CLARITHROMYCIN ON DAPSONE (D) DISPOSITION AND METHEMOGLOBIN CONCENTRATIONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 163-163
Citation: Co. Andrews et Jh. Fischer, GABAPENTIN - A NEW AGENT FOR THE MANAGEMENT OF EPILEPSY, The Annals of pharmacotherapy, 28(10), 1994, pp. 1188-1196
Citation: Jj. Grawe et al., REVERSAL OF THE ELECTROCARDIOGRAPHIC EFFECTS OF COCAINE BY LIDOCAINE .2. CONCENTRATION-EFFECT RELATIONSHIPS, Pharmacotherapy, 14(6), 1994, pp. 704-711
Authors:
KRAUS DM
HATZOPOULOS FK
REITZ SJ
FISCHER JH
Citation: Dm. Kraus et al., PHARMACOKINETIC EVALUATION OF 2 THEOPHYLLINE DOSING METHODS FOR INFANTS, Therapeutic drug monitoring, 16(3), 1994, pp. 270-276
Citation: Da. Piscitelli et al., BIOAVAILABILITY OF TOTAL AND UNBOUND DISOPYRAMIDE - IMPLICATIONS FOR CLINICAL USE OF THE IMMEDIATE AND CONTROLLED-RELEASE DOSAGE FORMS, Journal of clinical pharmacology, 34(8), 1994, pp. 823-828
Citation: Jh. Fischer et al., ADDING A NEW PRINCIPLE TO HYPOTHERMIC STORAGE PRESERVATION - REDUCTION OF EDEMA FORMATION BY HYALURONIDASE, Transplantation, 58(6), 1994, pp. 748-753
Authors:
PISCITELLI SC
OCCHIPINTI DJ
DANZIGER LH
HILL C
WEST DP
FISCHER JH
Citation: Sc. Piscitelli et al., THERAPEUTIC MONITORING AND PHARMACIST INTERVENTION IN A HANSENS-DISEASE CLINIC, The Annals of pharmacotherapy, 27(12), 1993, pp. 1526-1531
Authors:
KRAUS DM
FISCHER JH
REITZ SJ
KECSKES SA
YEH TF
MCCULLOCH KM
TUNG EC
CWIK MJ
Citation: Dm. Kraus et al., ALTERATIONS IN THEOPHYLLINE METABOLISM DURING THE 1ST YEAR OF LIFE, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 351-359